parp 1 protein Search Results


93
Sino Biological parp 1 protein
Design of 68 Ga-DOTA-Olaparib for <t>PARP-1</t> binding. ( a ) Chemical structure of the PARP-1 inhibitor Olaparib. ( b ) Co-crystal structure of Olaparib bound to the PARP-1 catalytic domain (PDB ID: 5DS3). ( c ) Chemical structure of DOTA-Olaparib. ( d ) Molecular docking of DOTA-Olaparib to PARP-1. ( e ) H-bonding interactions between DOTA-Olaparib and PARP-1 residues
Parp 1 Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/parp 1 protein/product/Sino Biological
Average 93 stars, based on 1 article reviews
parp 1 protein - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Shanghai Korain Biotech Co Ltd cleaved parp
Design of 68 Ga-DOTA-Olaparib for <t>PARP-1</t> binding. ( a ) Chemical structure of the PARP-1 inhibitor Olaparib. ( b ) Co-crystal structure of Olaparib bound to the PARP-1 catalytic domain (PDB ID: 5DS3). ( c ) Chemical structure of DOTA-Olaparib. ( d ) Molecular docking of DOTA-Olaparib to PARP-1. ( e ) H-bonding interactions between DOTA-Olaparib and PARP-1 residues
Cleaved Parp, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cleaved parp/product/Shanghai Korain Biotech Co Ltd
Average 93 stars, based on 1 article reviews
cleaved parp - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

95
Proteintech parp1
Design of 68 Ga-DOTA-Olaparib for <t>PARP-1</t> binding. ( a ) Chemical structure of the PARP-1 inhibitor Olaparib. ( b ) Co-crystal structure of Olaparib bound to the PARP-1 catalytic domain (PDB ID: 5DS3). ( c ) Chemical structure of DOTA-Olaparib. ( d ) Molecular docking of DOTA-Olaparib to PARP-1. ( e ) H-bonding interactions between DOTA-Olaparib and PARP-1 residues
Parp1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/parp1/product/Proteintech
Average 95 stars, based on 1 article reviews
parp1 - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

92
Rockland Immunochemicals rabbit anti ha
Design of 68 Ga-DOTA-Olaparib for <t>PARP-1</t> binding. ( a ) Chemical structure of the PARP-1 inhibitor Olaparib. ( b ) Co-crystal structure of Olaparib bound to the PARP-1 catalytic domain (PDB ID: 5DS3). ( c ) Chemical structure of DOTA-Olaparib. ( d ) Molecular docking of DOTA-Olaparib to PARP-1. ( e ) H-bonding interactions between DOTA-Olaparib and PARP-1 residues
Rabbit Anti Ha, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti ha/product/Rockland Immunochemicals
Average 92 stars, based on 1 article reviews
rabbit anti ha - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

93
Boster Bio antibodies against parp 1
Design of 68 Ga-DOTA-Olaparib for <t>PARP-1</t> binding. ( a ) Chemical structure of the PARP-1 inhibitor Olaparib. ( b ) Co-crystal structure of Olaparib bound to the PARP-1 catalytic domain (PDB ID: 5DS3). ( c ) Chemical structure of DOTA-Olaparib. ( d ) Molecular docking of DOTA-Olaparib to PARP-1. ( e ) H-bonding interactions between DOTA-Olaparib and PARP-1 residues
Antibodies Against Parp 1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against parp 1/product/Boster Bio
Average 93 stars, based on 1 article reviews
antibodies against parp 1 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Sino Biological parp
(A) <t>PARP-1</t> domains. FI-FIII are Zinc finger domains. Arrow shows the caspase-3/7 cleavage site.
Parp, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/parp/product/Sino Biological
Average 93 stars, based on 1 article reviews
parp - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

92
OriGene full length parp1
<t>PARP1</t> PARylates NAT10 at K1016, K1017, and K1020 both in vitro and in vivo. A Four GST-NAT10 deletion mutants (∆1–201, ∆202–488, ∆489–753, and ∆754–1025) and GST control were bacterially purified, and subjected to in vitro PARation assay in the presence of PARP1 and NAD + . The reaction samples were resolved by SDS-PAGE, and analyzed by immunoblotting analyses with anti-PAR and anti-GST antibodies. B In vitro PARylation assays were performed using purified GST-NAT10 deletion fragments in the presence or absence of recombinant PARP1 enzyme, NAD + , and Olaparib. PARylated NAT10 was detected with an anti-PAR antibody. C – E GST-NAT10 deletion fragments were subjected to in vitro PARation assay as described in A. F , G Purified GST-NAT10 754–1025 proteins (WT, K1016A, K1017A, D1018A, and K1020A, K3A) were subjected to in vitro PARation assays in the presence of PARP1 and NAD + . PARylation of NAT10 was detected by immunoblotting with an anti-PAR antibody. In G, K3A represents the combined mutation in all three residues (K1016, K1017, and K1020). H Alignment of the NAT10 protein sequence among different organisms. Asterisk (*) indicates the full conservation of the residues of NAT10 among different species. I , J MCF-7 cells were transfected with HA-NAT10 or HA-NAT10 K3A expression vector. After 48 h of transfection, cells were treated with or without 1 mM MMS for 2 h ( I ) or 6 Gy IR ( J ). Thereafter, IP and immunoblotting analyses were conducted with the indicated antibodies
Full Length Parp1, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/full length parp1/product/OriGene
Average 92 stars, based on 1 article reviews
full length parp1 - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

92
Shanghai Korain Biotech Co Ltd human poly
<t>PARP1</t> PARylates NAT10 at K1016, K1017, and K1020 both in vitro and in vivo. A Four GST-NAT10 deletion mutants (∆1–201, ∆202–488, ∆489–753, and ∆754–1025) and GST control were bacterially purified, and subjected to in vitro PARation assay in the presence of PARP1 and NAD + . The reaction samples were resolved by SDS-PAGE, and analyzed by immunoblotting analyses with anti-PAR and anti-GST antibodies. B In vitro PARylation assays were performed using purified GST-NAT10 deletion fragments in the presence or absence of recombinant PARP1 enzyme, NAD + , and Olaparib. PARylated NAT10 was detected with an anti-PAR antibody. C – E GST-NAT10 deletion fragments were subjected to in vitro PARation assay as described in A. F , G Purified GST-NAT10 754–1025 proteins (WT, K1016A, K1017A, D1018A, and K1020A, K3A) were subjected to in vitro PARation assays in the presence of PARP1 and NAD + . PARylation of NAT10 was detected by immunoblotting with an anti-PAR antibody. In G, K3A represents the combined mutation in all three residues (K1016, K1017, and K1020). H Alignment of the NAT10 protein sequence among different organisms. Asterisk (*) indicates the full conservation of the residues of NAT10 among different species. I , J MCF-7 cells were transfected with HA-NAT10 or HA-NAT10 K3A expression vector. After 48 h of transfection, cells were treated with or without 1 mM MMS for 2 h ( I ) or 6 Gy IR ( J ). Thereafter, IP and immunoblotting analyses were conducted with the indicated antibodies
Human Poly, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human poly/product/Shanghai Korain Biotech Co Ltd
Average 92 stars, based on 1 article reviews
human poly - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

90
Schmid GmbH poly(adp-ribose) polymerase
<t>PARP1</t> PARylates NAT10 at K1016, K1017, and K1020 both in vitro and in vivo. A Four GST-NAT10 deletion mutants (∆1–201, ∆202–488, ∆489–753, and ∆754–1025) and GST control were bacterially purified, and subjected to in vitro PARation assay in the presence of PARP1 and NAD + . The reaction samples were resolved by SDS-PAGE, and analyzed by immunoblotting analyses with anti-PAR and anti-GST antibodies. B In vitro PARylation assays were performed using purified GST-NAT10 deletion fragments in the presence or absence of recombinant PARP1 enzyme, NAD + , and Olaparib. PARylated NAT10 was detected with an anti-PAR antibody. C – E GST-NAT10 deletion fragments were subjected to in vitro PARation assay as described in A. F , G Purified GST-NAT10 754–1025 proteins (WT, K1016A, K1017A, D1018A, and K1020A, K3A) were subjected to in vitro PARation assays in the presence of PARP1 and NAD + . PARylation of NAT10 was detected by immunoblotting with an anti-PAR antibody. In G, K3A represents the combined mutation in all three residues (K1016, K1017, and K1020). H Alignment of the NAT10 protein sequence among different organisms. Asterisk (*) indicates the full conservation of the residues of NAT10 among different species. I , J MCF-7 cells were transfected with HA-NAT10 or HA-NAT10 K3A expression vector. After 48 h of transfection, cells were treated with or without 1 mM MMS for 2 h ( I ) or 6 Gy IR ( J ). Thereafter, IP and immunoblotting analyses were conducted with the indicated antibodies
Poly(adp Ribose) Polymerase, supplied by Schmid GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/poly(adp-ribose) polymerase/product/Schmid GmbH
Average 90 stars, based on 1 article reviews
poly(adp-ribose) polymerase - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Takeda parp-1 knockout
<t>PARP1</t> PARylates NAT10 at K1016, K1017, and K1020 both in vitro and in vivo. A Four GST-NAT10 deletion mutants (∆1–201, ∆202–488, ∆489–753, and ∆754–1025) and GST control were bacterially purified, and subjected to in vitro PARation assay in the presence of PARP1 and NAD + . The reaction samples were resolved by SDS-PAGE, and analyzed by immunoblotting analyses with anti-PAR and anti-GST antibodies. B In vitro PARylation assays were performed using purified GST-NAT10 deletion fragments in the presence or absence of recombinant PARP1 enzyme, NAD + , and Olaparib. PARylated NAT10 was detected with an anti-PAR antibody. C – E GST-NAT10 deletion fragments were subjected to in vitro PARation assay as described in A. F , G Purified GST-NAT10 754–1025 proteins (WT, K1016A, K1017A, D1018A, and K1020A, K3A) were subjected to in vitro PARation assays in the presence of PARP1 and NAD + . PARylation of NAT10 was detected by immunoblotting with an anti-PAR antibody. In G, K3A represents the combined mutation in all three residues (K1016, K1017, and K1020). H Alignment of the NAT10 protein sequence among different organisms. Asterisk (*) indicates the full conservation of the residues of NAT10 among different species. I , J MCF-7 cells were transfected with HA-NAT10 or HA-NAT10 K3A expression vector. After 48 h of transfection, cells were treated with or without 1 mM MMS for 2 h ( I ) or 6 Gy IR ( J ). Thereafter, IP and immunoblotting analyses were conducted with the indicated antibodies
Parp 1 Knockout, supplied by Takeda, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/parp-1 knockout/product/Takeda
Average 90 stars, based on 1 article reviews
parp-1 knockout - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Nagai Nori USA INC parp1 protein
<t>PARP1</t> PARylates NAT10 at K1016, K1017, and K1020 both in vitro and in vivo. A Four GST-NAT10 deletion mutants (∆1–201, ∆202–488, ∆489–753, and ∆754–1025) and GST control were bacterially purified, and subjected to in vitro PARation assay in the presence of PARP1 and NAD + . The reaction samples were resolved by SDS-PAGE, and analyzed by immunoblotting analyses with anti-PAR and anti-GST antibodies. B In vitro PARylation assays were performed using purified GST-NAT10 deletion fragments in the presence or absence of recombinant PARP1 enzyme, NAD + , and Olaparib. PARylated NAT10 was detected with an anti-PAR antibody. C – E GST-NAT10 deletion fragments were subjected to in vitro PARation assay as described in A. F , G Purified GST-NAT10 754–1025 proteins (WT, K1016A, K1017A, D1018A, and K1020A, K3A) were subjected to in vitro PARation assays in the presence of PARP1 and NAD + . PARylation of NAT10 was detected by immunoblotting with an anti-PAR antibody. In G, K3A represents the combined mutation in all three residues (K1016, K1017, and K1020). H Alignment of the NAT10 protein sequence among different organisms. Asterisk (*) indicates the full conservation of the residues of NAT10 among different species. I , J MCF-7 cells were transfected with HA-NAT10 or HA-NAT10 K3A expression vector. After 48 h of transfection, cells were treated with or without 1 mM MMS for 2 h ( I ) or 6 Gy IR ( J ). Thereafter, IP and immunoblotting analyses were conducted with the indicated antibodies
Parp1 Protein, supplied by Nagai Nori USA INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/parp1 protein/product/Nagai Nori USA INC
Average 90 stars, based on 1 article reviews
parp1 protein - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Hottinger Baldwin Messtechnik parp-1 protein
<t>PARP1</t> PARylates NAT10 at K1016, K1017, and K1020 both in vitro and in vivo. A Four GST-NAT10 deletion mutants (∆1–201, ∆202–488, ∆489–753, and ∆754–1025) and GST control were bacterially purified, and subjected to in vitro PARation assay in the presence of PARP1 and NAD + . The reaction samples were resolved by SDS-PAGE, and analyzed by immunoblotting analyses with anti-PAR and anti-GST antibodies. B In vitro PARylation assays were performed using purified GST-NAT10 deletion fragments in the presence or absence of recombinant PARP1 enzyme, NAD + , and Olaparib. PARylated NAT10 was detected with an anti-PAR antibody. C – E GST-NAT10 deletion fragments were subjected to in vitro PARation assay as described in A. F , G Purified GST-NAT10 754–1025 proteins (WT, K1016A, K1017A, D1018A, and K1020A, K3A) were subjected to in vitro PARation assays in the presence of PARP1 and NAD + . PARylation of NAT10 was detected by immunoblotting with an anti-PAR antibody. In G, K3A represents the combined mutation in all three residues (K1016, K1017, and K1020). H Alignment of the NAT10 protein sequence among different organisms. Asterisk (*) indicates the full conservation of the residues of NAT10 among different species. I , J MCF-7 cells were transfected with HA-NAT10 or HA-NAT10 K3A expression vector. After 48 h of transfection, cells were treated with or without 1 mM MMS for 2 h ( I ) or 6 Gy IR ( J ). Thereafter, IP and immunoblotting analyses were conducted with the indicated antibodies
Parp 1 Protein, supplied by Hottinger Baldwin Messtechnik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/parp-1 protein/product/Hottinger Baldwin Messtechnik
Average 90 stars, based on 1 article reviews
parp-1 protein - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Design of 68 Ga-DOTA-Olaparib for PARP-1 binding. ( a ) Chemical structure of the PARP-1 inhibitor Olaparib. ( b ) Co-crystal structure of Olaparib bound to the PARP-1 catalytic domain (PDB ID: 5DS3). ( c ) Chemical structure of DOTA-Olaparib. ( d ) Molecular docking of DOTA-Olaparib to PARP-1. ( e ) H-bonding interactions between DOTA-Olaparib and PARP-1 residues

Journal: European Journal of Nuclear Medicine and Molecular Imaging

Article Title: PET imaging of PARP expression using 68 Ga-labelled inhibitors

doi: 10.1007/s00259-023-06249-6

Figure Lengend Snippet: Design of 68 Ga-DOTA-Olaparib for PARP-1 binding. ( a ) Chemical structure of the PARP-1 inhibitor Olaparib. ( b ) Co-crystal structure of Olaparib bound to the PARP-1 catalytic domain (PDB ID: 5DS3). ( c ) Chemical structure of DOTA-Olaparib. ( d ) Molecular docking of DOTA-Olaparib to PARP-1. ( e ) H-bonding interactions between DOTA-Olaparib and PARP-1 residues

Article Snippet: The PARP-1 protein (human, 11,040-H08B, Recombinant (His Tag)) was from Sino Biological.

Techniques: Binding Assay

Cell uptake of the three 68 Ga-labelled radiotracers. ( a ) Western blot analysis probing the expression of PARP-1 in A549 and SK-OV-3 cells. ( b ) Cell uptake of the 68 Ga-labelled radiotracers in SK-OV-3 and A549 cells after 2 h of incubation. ( c ) The SK-OV-3/A549 uptake ratios of the. 68 Ga-labelled radiotracers. ( d ) Confocal images of cells stained with FL-Olaparib (green, left) and DAPI (blue, middle) alone. Confocal image of cells stained with FL-Olaparib and DAPI (right). ( e ) Confocal images of cells stained with FL-Olaparib with a 100-fold excess of Olaparib (left) and DAPI (blue, middle) alone. Confocal image of cells stained with FL-Olaparib with DAPI and a 100-fold excess of Olaparib (right). ( f ) Confocal images of cells stained with FL-Olaparib with a 1000-fold excess of DOTA-Olaparib (left) and DAPI (blue, middle) alone. Confocal image of cells stained with FL-Olaparib with DAPI and a 1000-fold excess of DOTA-Olaparib (right)

Journal: European Journal of Nuclear Medicine and Molecular Imaging

Article Title: PET imaging of PARP expression using 68 Ga-labelled inhibitors

doi: 10.1007/s00259-023-06249-6

Figure Lengend Snippet: Cell uptake of the three 68 Ga-labelled radiotracers. ( a ) Western blot analysis probing the expression of PARP-1 in A549 and SK-OV-3 cells. ( b ) Cell uptake of the 68 Ga-labelled radiotracers in SK-OV-3 and A549 cells after 2 h of incubation. ( c ) The SK-OV-3/A549 uptake ratios of the. 68 Ga-labelled radiotracers. ( d ) Confocal images of cells stained with FL-Olaparib (green, left) and DAPI (blue, middle) alone. Confocal image of cells stained with FL-Olaparib and DAPI (right). ( e ) Confocal images of cells stained with FL-Olaparib with a 100-fold excess of Olaparib (left) and DAPI (blue, middle) alone. Confocal image of cells stained with FL-Olaparib with DAPI and a 100-fold excess of Olaparib (right). ( f ) Confocal images of cells stained with FL-Olaparib with a 1000-fold excess of DOTA-Olaparib (left) and DAPI (blue, middle) alone. Confocal image of cells stained with FL-Olaparib with DAPI and a 1000-fold excess of DOTA-Olaparib (right)

Article Snippet: The PARP-1 protein (human, 11,040-H08B, Recombinant (His Tag)) was from Sino Biological.

Techniques: Western Blot, Expressing, Incubation, Staining

Association of 68 Ga-DOTA-Olaparib signalling with PARP-1 expression at the tumor tissue level. ( a ) Autoradiography and ( b ) H&E staining of SK-OV-3 models injected with 68 Ga-DOTA-Olaparib. ( c ) Representative image showing PARP-1 immunohistochemical staining

Journal: European Journal of Nuclear Medicine and Molecular Imaging

Article Title: PET imaging of PARP expression using 68 Ga-labelled inhibitors

doi: 10.1007/s00259-023-06249-6

Figure Lengend Snippet: Association of 68 Ga-DOTA-Olaparib signalling with PARP-1 expression at the tumor tissue level. ( a ) Autoradiography and ( b ) H&E staining of SK-OV-3 models injected with 68 Ga-DOTA-Olaparib. ( c ) Representative image showing PARP-1 immunohistochemical staining

Article Snippet: The PARP-1 protein (human, 11,040-H08B, Recombinant (His Tag)) was from Sino Biological.

Techniques: Expressing, Autoradiography, Staining, Injection, Immunohistochemical staining

(A) PARP-1 domains. FI-FIII are Zinc finger domains. Arrow shows the caspase-3/7 cleavage site.

Journal: Molecular cell

Article Title: SPARCLE , a p53-induced lncRNA, controls apoptosis after genotoxic stress by promoting PARP-1 cleavage

doi: 10.1016/j.molcel.2022.01.001

Figure Lengend Snippet: (A) PARP-1 domains. FI-FIII are Zinc finger domains. Arrow shows the caspase-3/7 cleavage site.

Article Snippet: In vitro transcription 2 μg of linearized plasmid encoding full-length SPARCLE ( SPARCLE 3K ), the first 75 nt ( SPARCLE 75 ), 178 nt ( SPARCLE 178 ) or 275 nt ( SPARCLE 275 ) of SPARCLE sequence or the reverse sequence of SPARCLE 275 ( ELCRAPS ) were in vitro transcribed using the MEGAScript T7 transcription kit (AM1334, ThermoFisher Scientific) following the manufacturer’s directions, but with increased incubation time (6 hr). . PARP-1 in vitro cleavage 50 ng of human recombinant full-length PARP-1 protein (11040-H08B, Sino Biological) were incubated at 37°C for 10 min with 0.5 units of human recombinant cleaved Caspase 3 protein (ab52101, Abcam) and with the indicated amount of in vitro transcribed SPARCLE 75 , SPARCLE 178 , SPARCLE 275 or ELCRAPS .

Techniques:

PARP1 PARylates NAT10 at K1016, K1017, and K1020 both in vitro and in vivo. A Four GST-NAT10 deletion mutants (∆1–201, ∆202–488, ∆489–753, and ∆754–1025) and GST control were bacterially purified, and subjected to in vitro PARation assay in the presence of PARP1 and NAD + . The reaction samples were resolved by SDS-PAGE, and analyzed by immunoblotting analyses with anti-PAR and anti-GST antibodies. B In vitro PARylation assays were performed using purified GST-NAT10 deletion fragments in the presence or absence of recombinant PARP1 enzyme, NAD + , and Olaparib. PARylated NAT10 was detected with an anti-PAR antibody. C – E GST-NAT10 deletion fragments were subjected to in vitro PARation assay as described in A. F , G Purified GST-NAT10 754–1025 proteins (WT, K1016A, K1017A, D1018A, and K1020A, K3A) were subjected to in vitro PARation assays in the presence of PARP1 and NAD + . PARylation of NAT10 was detected by immunoblotting with an anti-PAR antibody. In G, K3A represents the combined mutation in all three residues (K1016, K1017, and K1020). H Alignment of the NAT10 protein sequence among different organisms. Asterisk (*) indicates the full conservation of the residues of NAT10 among different species. I , J MCF-7 cells were transfected with HA-NAT10 or HA-NAT10 K3A expression vector. After 48 h of transfection, cells were treated with or without 1 mM MMS for 2 h ( I ) or 6 Gy IR ( J ). Thereafter, IP and immunoblotting analyses were conducted with the indicated antibodies

Journal: Cell Communication and Signaling : CCS

Article Title: Poly(ADP-ribosyl)ation of acetyltransferase NAT10 by PARP1 is required for its nucleoplasmic translocation and function in response to DNA damage

doi: 10.1186/s12964-022-00932-1

Figure Lengend Snippet: PARP1 PARylates NAT10 at K1016, K1017, and K1020 both in vitro and in vivo. A Four GST-NAT10 deletion mutants (∆1–201, ∆202–488, ∆489–753, and ∆754–1025) and GST control were bacterially purified, and subjected to in vitro PARation assay in the presence of PARP1 and NAD + . The reaction samples were resolved by SDS-PAGE, and analyzed by immunoblotting analyses with anti-PAR and anti-GST antibodies. B In vitro PARylation assays were performed using purified GST-NAT10 deletion fragments in the presence or absence of recombinant PARP1 enzyme, NAD + , and Olaparib. PARylated NAT10 was detected with an anti-PAR antibody. C – E GST-NAT10 deletion fragments were subjected to in vitro PARation assay as described in A. F , G Purified GST-NAT10 754–1025 proteins (WT, K1016A, K1017A, D1018A, and K1020A, K3A) were subjected to in vitro PARation assays in the presence of PARP1 and NAD + . PARylation of NAT10 was detected by immunoblotting with an anti-PAR antibody. In G, K3A represents the combined mutation in all three residues (K1016, K1017, and K1020). H Alignment of the NAT10 protein sequence among different organisms. Asterisk (*) indicates the full conservation of the residues of NAT10 among different species. I , J MCF-7 cells were transfected with HA-NAT10 or HA-NAT10 K3A expression vector. After 48 h of transfection, cells were treated with or without 1 mM MMS for 2 h ( I ) or 6 Gy IR ( J ). Thereafter, IP and immunoblotting analyses were conducted with the indicated antibodies

Article Snippet: The purified GST-NAT10 fragment (1 μg) was incubated with 100 ng of recombinant full-length PARP1 (Origene, #TP710053) in a reaction buffer containing 100 mM Tris–HCl (pH 8.0), 10 mM MgCl 2 , 1 mM DTT, 4 ng/ml sonicated salmon sperm DNA (Invitrogen, #AM9680), and 300 μM nicotinamide adenine dinucleotide (NAD + ) at 37 °C for 30 min.

Techniques: In Vitro, In Vivo, Purification, SDS Page, Western Blot, Recombinant, Mutagenesis, Sequencing, Transfection, Expressing, Plasmid Preparation

PARylation of NAT10 by PARP1 regulates its nucleoplasmic translocation and co-localization with MORC2. A MCF-7 cells were transfected with plasmid DNAs encoding Flag-MORC2, HA-NAT10, or HA-NAT10 K3A. After 48 h of transfection, cells were treated with or without 1 mM MMS for 2 h or 6 Gy IR. IF staining was performed with an anti-Flag (green) or anti-HA (red) antibody. DNA was counterstained with DAPI (blue). Scale bar, 2.5 μm. The quantitative results of cells with NAT10 nucleoplasmic translocation are presented in the right panel. ** p < 0.01; NS , no significance. B , C MCF-7 cells were transfected with HA-NAT10 and Flag-MORC2. After 48 h of transfection, cells were pretreated with or without 10 μM Olaparib for 3 h, and then treated with or without 1 mM MMS for another 2 h ( B ) or 6 Gy IR ( C ). IF staining was performed with an anti-Flag (green) or anti-HA (red) antibody. DNA was counterstained with DAPI (blue). Scale bar, 2.5 μm. The quantitative results of cells with NAT10 nucleoplasmic translocation are displayed in the right panel. ** p < 0.01; *** p < 0.001. D , E PARP1-KO MCF-7 cells were transfected with HA-NAT10 and Flag-MORC2. After 48 h of transfection, cells were treated with or without 1 mM MMS for another 2 h ( D ) or 6 Gy IR ( E ). IF staining was performed with an anti-Flag (green) or anti-HA (red) antibody. DNA was counterstained with DAPI (blue). Scale bar, 2.5 μm. The quantitative results of cells with NAT10 nucleoplasmic translocation are displayed in the right panel. ** p < 0.01; *** p < 0.001. Arrows indicate the colocalization between MORC2 and NAT10

Journal: Cell Communication and Signaling : CCS

Article Title: Poly(ADP-ribosyl)ation of acetyltransferase NAT10 by PARP1 is required for its nucleoplasmic translocation and function in response to DNA damage

doi: 10.1186/s12964-022-00932-1

Figure Lengend Snippet: PARylation of NAT10 by PARP1 regulates its nucleoplasmic translocation and co-localization with MORC2. A MCF-7 cells were transfected with plasmid DNAs encoding Flag-MORC2, HA-NAT10, or HA-NAT10 K3A. After 48 h of transfection, cells were treated with or without 1 mM MMS for 2 h or 6 Gy IR. IF staining was performed with an anti-Flag (green) or anti-HA (red) antibody. DNA was counterstained with DAPI (blue). Scale bar, 2.5 μm. The quantitative results of cells with NAT10 nucleoplasmic translocation are presented in the right panel. ** p < 0.01; NS , no significance. B , C MCF-7 cells were transfected with HA-NAT10 and Flag-MORC2. After 48 h of transfection, cells were pretreated with or without 10 μM Olaparib for 3 h, and then treated with or without 1 mM MMS for another 2 h ( B ) or 6 Gy IR ( C ). IF staining was performed with an anti-Flag (green) or anti-HA (red) antibody. DNA was counterstained with DAPI (blue). Scale bar, 2.5 μm. The quantitative results of cells with NAT10 nucleoplasmic translocation are displayed in the right panel. ** p < 0.01; *** p < 0.001. D , E PARP1-KO MCF-7 cells were transfected with HA-NAT10 and Flag-MORC2. After 48 h of transfection, cells were treated with or without 1 mM MMS for another 2 h ( D ) or 6 Gy IR ( E ). IF staining was performed with an anti-Flag (green) or anti-HA (red) antibody. DNA was counterstained with DAPI (blue). Scale bar, 2.5 μm. The quantitative results of cells with NAT10 nucleoplasmic translocation are displayed in the right panel. ** p < 0.01; *** p < 0.001. Arrows indicate the colocalization between MORC2 and NAT10

Article Snippet: The purified GST-NAT10 fragment (1 μg) was incubated with 100 ng of recombinant full-length PARP1 (Origene, #TP710053) in a reaction buffer containing 100 mM Tris–HCl (pH 8.0), 10 mM MgCl 2 , 1 mM DTT, 4 ng/ml sonicated salmon sperm DNA (Invitrogen, #AM9680), and 300 μM nicotinamide adenine dinucleotide (NAD + ) at 37 °C for 30 min.

Techniques: Translocation Assay, Transfection, Plasmid Preparation, Staining

PARylation of NAT10 by PARP1 regulates its interaction with MORC2. A HEK293T cells were transfected with the indicated expression vectors. After 48 h of transfection, cells were treated with or without 1 mM MMS for 2 h and subjected to IP and immunoblotting analyses with the indicated antibodies. B , C BT549 cells were transfected with plasmid DNAs encoding pCDH, HA-NAT10, or HA-NAT10 K3A. After 48 h of transfection, cells were treated with or without 1 mM MMS for 2 h ( B ) or 6 Gy IR ( C ). IP and immunoblotting analyses were performed with the indicated antibodies. D – F MCF-7 and BT549 cells were pretreated with or without 10 μM Olaparib for 3 h, and then treated with or without 1 mM MMS for another 2 h. The sequential IP and immunoblotting analyses were performed with the indicated antibodies. G – I MCF-7 and BT549 cells were pretreated with or without 10 μM Olaparib for 3 h, and then treated with or without 6 Gy IR. The sequential IP and immunoblotting analyses were performed with the indicated antibodies

Journal: Cell Communication and Signaling : CCS

Article Title: Poly(ADP-ribosyl)ation of acetyltransferase NAT10 by PARP1 is required for its nucleoplasmic translocation and function in response to DNA damage

doi: 10.1186/s12964-022-00932-1

Figure Lengend Snippet: PARylation of NAT10 by PARP1 regulates its interaction with MORC2. A HEK293T cells were transfected with the indicated expression vectors. After 48 h of transfection, cells were treated with or without 1 mM MMS for 2 h and subjected to IP and immunoblotting analyses with the indicated antibodies. B , C BT549 cells were transfected with plasmid DNAs encoding pCDH, HA-NAT10, or HA-NAT10 K3A. After 48 h of transfection, cells were treated with or without 1 mM MMS for 2 h ( B ) or 6 Gy IR ( C ). IP and immunoblotting analyses were performed with the indicated antibodies. D – F MCF-7 and BT549 cells were pretreated with or without 10 μM Olaparib for 3 h, and then treated with or without 1 mM MMS for another 2 h. The sequential IP and immunoblotting analyses were performed with the indicated antibodies. G – I MCF-7 and BT549 cells were pretreated with or without 10 μM Olaparib for 3 h, and then treated with or without 6 Gy IR. The sequential IP and immunoblotting analyses were performed with the indicated antibodies

Article Snippet: The purified GST-NAT10 fragment (1 μg) was incubated with 100 ng of recombinant full-length PARP1 (Origene, #TP710053) in a reaction buffer containing 100 mM Tris–HCl (pH 8.0), 10 mM MgCl 2 , 1 mM DTT, 4 ng/ml sonicated salmon sperm DNA (Invitrogen, #AM9680), and 300 μM nicotinamide adenine dinucleotide (NAD + ) at 37 °C for 30 min.

Techniques: Transfection, Expressing, Western Blot, Plasmid Preparation

PARylation of NAT10 by PARP1 regulates MORC2 acetylation in response to DNA damage. A , B NAT10-KO MCF-7 and BT549 cells were transfected with plasmid DNAs encoding pCDH, HA-NAT10, or HA-NAT10 K3A. After 48 h of transfection, cells were treated with or without 1 mM MMS for 2 h ( A ) or 6 Gy IR ( B ), and then subjected to IP and immunoblotting with the indicated antibodies

Journal: Cell Communication and Signaling : CCS

Article Title: Poly(ADP-ribosyl)ation of acetyltransferase NAT10 by PARP1 is required for its nucleoplasmic translocation and function in response to DNA damage

doi: 10.1186/s12964-022-00932-1

Figure Lengend Snippet: PARylation of NAT10 by PARP1 regulates MORC2 acetylation in response to DNA damage. A , B NAT10-KO MCF-7 and BT549 cells were transfected with plasmid DNAs encoding pCDH, HA-NAT10, or HA-NAT10 K3A. After 48 h of transfection, cells were treated with or without 1 mM MMS for 2 h ( A ) or 6 Gy IR ( B ), and then subjected to IP and immunoblotting with the indicated antibodies

Article Snippet: The purified GST-NAT10 fragment (1 μg) was incubated with 100 ng of recombinant full-length PARP1 (Origene, #TP710053) in a reaction buffer containing 100 mM Tris–HCl (pH 8.0), 10 mM MgCl 2 , 1 mM DTT, 4 ng/ml sonicated salmon sperm DNA (Invitrogen, #AM9680), and 300 μM nicotinamide adenine dinucleotide (NAD + ) at 37 °C for 30 min.

Techniques: Transfection, Plasmid Preparation, Western Blot

DNA damage induces MORC2 K767Ac in a PARP1-dependent manner. A MCF-7 cells were pretreated with or without 10 μM ATM inhibitor (KU-55933), 10 μM ATR inhibitor (VE-821), 10 μM DNA-PKcs inhibitor (NU7441), and 10 μM PARP inhibitor (Olaparib) for 3 h, and then treated with 1 mM MMS for 1 h. IP and immunoblotting analyses were performed with the indicated antibodies. Positive controls for these inhibitors are shown in the input. B HEK293T cells stably expressing pCDH and Flag-MORC2 were pretreated with or without 10 μM Olaparib for 3 h, and then treated with 1 mM MMS for another 2 h or 6 Gy IR. IP and immunoblotting analyses were performed with the indicated antibodies. C MCF-7 and BT549 cells were pretreated with or without 10 μM Olaparib for 3 h, and then treated with 1 mM MMS for another 2 h or 6 Gy IR. IP and immunoblotting analyses were performed with the indicated antibodies. D WT and PARP1-KO MCF-7 cells were treated with or without 1 mM MMS for 2 h or 6 Gy IR. Thereafter, IP and immunoblotting analyses were carried out with the inidicated antibodies. E BT549 cells were transfected with siNC or two independent siRNA targeting PARP1 (siPARP1). After 48 h of transfection, cells were treated with or without 1 mM MMS for 2 h or 6 Gy IR. IP and immunoblotting analyses were subsequently performed with the indicated antibodies

Journal: Cell Communication and Signaling : CCS

Article Title: Poly(ADP-ribosyl)ation of acetyltransferase NAT10 by PARP1 is required for its nucleoplasmic translocation and function in response to DNA damage

doi: 10.1186/s12964-022-00932-1

Figure Lengend Snippet: DNA damage induces MORC2 K767Ac in a PARP1-dependent manner. A MCF-7 cells were pretreated with or without 10 μM ATM inhibitor (KU-55933), 10 μM ATR inhibitor (VE-821), 10 μM DNA-PKcs inhibitor (NU7441), and 10 μM PARP inhibitor (Olaparib) for 3 h, and then treated with 1 mM MMS for 1 h. IP and immunoblotting analyses were performed with the indicated antibodies. Positive controls for these inhibitors are shown in the input. B HEK293T cells stably expressing pCDH and Flag-MORC2 were pretreated with or without 10 μM Olaparib for 3 h, and then treated with 1 mM MMS for another 2 h or 6 Gy IR. IP and immunoblotting analyses were performed with the indicated antibodies. C MCF-7 and BT549 cells were pretreated with or without 10 μM Olaparib for 3 h, and then treated with 1 mM MMS for another 2 h or 6 Gy IR. IP and immunoblotting analyses were performed with the indicated antibodies. D WT and PARP1-KO MCF-7 cells were treated with or without 1 mM MMS for 2 h or 6 Gy IR. Thereafter, IP and immunoblotting analyses were carried out with the inidicated antibodies. E BT549 cells were transfected with siNC or two independent siRNA targeting PARP1 (siPARP1). After 48 h of transfection, cells were treated with or without 1 mM MMS for 2 h or 6 Gy IR. IP and immunoblotting analyses were subsequently performed with the indicated antibodies

Article Snippet: The purified GST-NAT10 fragment (1 μg) was incubated with 100 ng of recombinant full-length PARP1 (Origene, #TP710053) in a reaction buffer containing 100 mM Tris–HCl (pH 8.0), 10 mM MgCl 2 , 1 mM DTT, 4 ng/ml sonicated salmon sperm DNA (Invitrogen, #AM9680), and 300 μM nicotinamide adenine dinucleotide (NAD + ) at 37 °C for 30 min.

Techniques: Western Blot, Stable Transfection, Expressing, Transfection

PARylation of NAT10 by PARP1 is required for cell survival in response to DNA damage. A , B NAT10-KO MCF-7 and BT549 cells stably expressing pCDH, HA-NAT10 WT, or HA-NAT10 K3A were treated with increasing doses of MMS and then subjected to clonogenic survival assays. Representative images of survival colonies are displayed in A and the corresponding quantitative results are shown in B . C , D NAT10-KO MCF-7 and BT549 cells stably expressing pCDH, HA-NAT10 WT, or HA-NAT10 K3A were treated with or without 6 Gy IR, and then subjected to clonogenic survival assays. Representative images of survival colonies are displayed in C and the corresponding quantitative results are shown in D

Journal: Cell Communication and Signaling : CCS

Article Title: Poly(ADP-ribosyl)ation of acetyltransferase NAT10 by PARP1 is required for its nucleoplasmic translocation and function in response to DNA damage

doi: 10.1186/s12964-022-00932-1

Figure Lengend Snippet: PARylation of NAT10 by PARP1 is required for cell survival in response to DNA damage. A , B NAT10-KO MCF-7 and BT549 cells stably expressing pCDH, HA-NAT10 WT, or HA-NAT10 K3A were treated with increasing doses of MMS and then subjected to clonogenic survival assays. Representative images of survival colonies are displayed in A and the corresponding quantitative results are shown in B . C , D NAT10-KO MCF-7 and BT549 cells stably expressing pCDH, HA-NAT10 WT, or HA-NAT10 K3A were treated with or without 6 Gy IR, and then subjected to clonogenic survival assays. Representative images of survival colonies are displayed in C and the corresponding quantitative results are shown in D

Article Snippet: The purified GST-NAT10 fragment (1 μg) was incubated with 100 ng of recombinant full-length PARP1 (Origene, #TP710053) in a reaction buffer containing 100 mM Tris–HCl (pH 8.0), 10 mM MgCl 2 , 1 mM DTT, 4 ng/ml sonicated salmon sperm DNA (Invitrogen, #AM9680), and 300 μM nicotinamide adenine dinucleotide (NAD + ) at 37 °C for 30 min.

Techniques: Stable Transfection, Expressing

The proposed working model. Activated PARP1 after DNA damage catalyzes the PARylation of NAT10, which is required for the translocation of NAT10 from the nucleolus to the nucleoplasm. NAT10 relocalization increases its co-localization and interaction with its substrate, MORC2, thereby enhancing MORC2 K767Ac in response to DNA damage

Journal: Cell Communication and Signaling : CCS

Article Title: Poly(ADP-ribosyl)ation of acetyltransferase NAT10 by PARP1 is required for its nucleoplasmic translocation and function in response to DNA damage

doi: 10.1186/s12964-022-00932-1

Figure Lengend Snippet: The proposed working model. Activated PARP1 after DNA damage catalyzes the PARylation of NAT10, which is required for the translocation of NAT10 from the nucleolus to the nucleoplasm. NAT10 relocalization increases its co-localization and interaction with its substrate, MORC2, thereby enhancing MORC2 K767Ac in response to DNA damage

Article Snippet: The purified GST-NAT10 fragment (1 μg) was incubated with 100 ng of recombinant full-length PARP1 (Origene, #TP710053) in a reaction buffer containing 100 mM Tris–HCl (pH 8.0), 10 mM MgCl 2 , 1 mM DTT, 4 ng/ml sonicated salmon sperm DNA (Invitrogen, #AM9680), and 300 μM nicotinamide adenine dinucleotide (NAD + ) at 37 °C for 30 min.

Techniques: Translocation Assay